8-K - Aspire Biopharma Holdings, Inc. | StockGist

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 2024 Stock In

Management Change

9.01

Financial Statements and Exhibits. d) Exhibits Exhibit No. Description 10.1 2024 Stock Incentive Plan 10.2 Form of Restricted Stock Unit Grant Notice and Agreem

Exhibits Only

Exhibits (4)

10.1

EX-10.1

10.2

EX-10.2

10.3

EX-10.3

8-K